// App-Quantinova.ai

4715 : Characterization of potential co-drivers of pathogenesis in ALK positive ALCL

Researchers

Presenter

  • Luca Mologni

Principal Investigators

  • Matteo Villa

  • Mario Mauri

  • Giulia Arosio

  • Cosimo Lobello

  • Hugo Larose

  • Alessandra Pirola

  • Silvia Bombelli

  • Nicoletta Cordani

  • Luca Massimino

  • rka Pospilov

  • Suzanne D. Turner

  • Giorgio Inghirami

  • Fabio Pagni

  • Rocco Piazza

  • Roberto Perego

  • Roberto Chiarle

  • Carlo Gambacorti-Passerini

Medical Centers

  • University of Milano-Bicocca, Monza, Italy

  • Masaryk University Hospital, Brno, Czech Republic

  • University of Cambridge, Cambridge, United Kingdom

  • Galseq srl, Italy

  • Universita Vita Salute San Raffaele, Milan, Italy

  • Weill Cornell Medical College, New York, NY

  • Boston Children's Hospital, Boston, MA

Locations

  • Italy

  • Czech Republic

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non-Hodgkin's Lymphoma

Biomarkers

  • beta-catenin

  • DNA Damage Inducible Transcript 3

Drug/Treatment

  • Crizotinib

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved